Nick Pizzie

2021

In 2021, Nick Pizzie earned a total compensation of $4.2M as Chief Financial Officer at Axsome Therapeutics, a 79% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$139,060
Option Awards$2,808,123
Salary$409,000
Stock Awards$866,617
Other$5,910
Total$4,228,710

Pizzie received $2.8M in option awards, accounting for 66% of the total pay in 2021.

Pizzie also received $139.1K in non-equity incentive plan, $409K in salary, $866.6K in stock awards and $5.9K in other compensation.

Rankings

In 2021, Nick Pizzie's compensation ranked 3,149th out of 12,415 executives tracked by ExecPay. In other words, Pizzie earned more than 74.6% of executives.

ClassificationRankingPercentile
All
3,149
out of 12,415
75th
Division
Manufacturing
1,270
out of 5,505
77th
Major group
Chemicals And Allied Products
519
out of 2,375
78th
Industry group
Drugs
460
out of 2,096
78th
Industry
Pharmaceutical Preparations
318
out of 1,546
79th

Pay ratio

Nick Pizzie's Pay$4,228,710
Median Employee's Pay$690,964
Pay Ratio

6

to 1

In 2021, the annual total compensation of Nick Pizzie was $4,228,710.

The annual total compensation of the median employee at Axsome Therapeutics was $690,964.

The ratio of Nick Pizzie's pay to the pay of median employee was therefore 6 to one.

Source: SEC filing on April 22, 2022.

Pizzie's colleagues

We found two more compensation records of executives who worked with Nick Pizzie at Axsome Therapeutics in 2021.

2021

Herriot Tabuteau

Axsome Therapeutics

Chief Executive Officer

2021

Mark MA

Axsome Therapeutics

Chief Operating Officer

News

In-depth

You may also like